FDA Approves Aimovig (erenumab-aooe) as a Preventive Treatment for Migraine

May 17, 2018 -- The U.S. Food and Drug Administration today approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news

Related Links:

Condition:   Migraine Interventions:   Behavioral: Clinical Decision Support Tool;   Behavioral: Headache Education Sponsors:   Albert Einstein College of Medicine, Inc.;   National Institute of Neurological Disorders and Stroke (NINDS) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
ConclusionTo the best of our knowledge, this case is the first report regarding the association between barotrauma and intracranial complications of acute rhinosinusitis. A high index of suspicion and well-timed surgical evacuation may ensure a full recovery.
Source: European Annals of Otorhinolaryngology, Head and Neck Diseases - Category: ENT & OMF Source Type: research
Publication date: Available online 15 October 2018Source: NeuroscienceAuthor(s): Simona Denise Frederiksen, Karin Warfvinge, Lena Ohlsson, Lars EdvinssonAbstractNeurotransmitter and headache target localization in the trigeminal ganglia (TG) might increase the understanding of sites of action, and mechanisms related to headache therapy. The overall aim of the study was to investigate the presence of migraine targets in the TG with particular emphasis on pituitary adenylate cyclase-activating peptide (PACAP) and calcitonin gene-related peptide (CGRP), known to be involved in cranial pain processing, and selected headache ta...
Source: Neuroscience - Category: Neuroscience Source Type: research
The company behind telehealth hair loss brand Keeps has raised $15 million to expand into a new market, migraines.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news
Edoardo Caronna, Victor Jos é Gallardo, Natalia Hernández-Beltrán, Marta Torres-Ferrus, Patricia Pozo-Rosich
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Migraine and Attention Deficit and Hyperactivity Disorder (ADHD) have been found to be associated in child and adolescent cohorts; however, the association has not been assessed in adults or otherwise healthy ...
Source: BMC Neurology - Category: Neurology Authors: Tags: Research article Source Type: research
ConclusionThis study demonstrated the practical gaps in counseling practices and poor headache management of community pharmacies in Gondar city. National stakeholders in collaboration with academic organizations should be involved in continuous clinical training and education regarding proper counseling practices.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
Headache: The Journal of Head and Face Pain, EarlyView.
Source: Headache: The Journal of Head and Face Pain - Category: Neurology Authors: Source Type: research
DiscussionIdentifying medium-term interventions able to improve chronic migraine is relevant to manage this illness. The present randomized trial might represent a step forward for managing chronic migraine by means of psychological interventions.Trial registrationClinicalTrial.gov Identifier:NCT03404336. Registered on 19 January 2018.
Source: Trials - Category: Research Source Type: clinical trials
The federal government imposes a mandate to blend corn ethanol and other biofuels into the nation ’s gasoline. This “renewable fuel standard” or RFS produces a range of negative effects, as discussed inthis study at DownsizingGovernment.The “10% Ethanol” sticker you see at the gas station indicates that the government is subverting your free choice and raising your driving costs to benefit corn farmers. The government has decided that corn farmers are more important than you are.President Trump has supported the ethanol mandate, and he recently acted to increase the harm by allowing greater us...
Source: Cato-at-liberty - Category: American Health Authors: Source Type: blogs
More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Headache | Migraine